Clicky

Illumina Inc.(0J8Z)

Description: Illumina, Inc. offers sequencing- and array-based solutions for genetic and genomic analysis in the United States, Singapore, the United Kingdom, and internationally. It operates through Core Illumina and GRAIL segments. The company offers sequencing and array-based instruments and consumables, which include reagents, flow cells, and library preparation; whole-genome sequencing kits, which sequence entire genomes of various size and complexity; and targeted resequencing kits, which sequence exomes, specific genes, and RNA or other genomic regions of interest. It also provides whole-genome sequencing, genotyping, noninvasive prenatal testing, and product support services; and Galleri, a multi-cancer early detection test. In addition, the company is developing solutions to help accelerate cancer diagnoses, blood-based detection for minimal residual disease, and other post-diagnostic applications. The company serves genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. It markets and distributes its products directly to customers, as well as through life-science distributors. Illumina, Inc. was incorporated in 1998 and is based in San Diego, California.


Keywords:

Home Page: www.illumina.com

0J8Z Technical Analysis

5200 Illumina Way
San Diego, CA 92122
United States
Phone: 858 202 4500


Officers

Name Title
Mr. Jacob Thaysen Ph.D. CEO & Director
Ms. Carissa L. Rollins Chief Information Officer
Mr. Charles E. Dadswell Esq. Advisor
Stephanie Campos President
Mr. Kevin Carl Pegels Chief of Global Operations
Mr. Scott Ericksen VP & Chief Accounting Officer
Dr. Steven Barnard Ph.D. Chief Technology Officer
Ms. Sallilyn Schwartz Vice President of Investor Relations
Mr. Scott Davies Interim General Counsel & Secretary
Mr. Jakob Wedel Chief Strategy & Corporate Development Officer and CEO Chief of Staff

Exchange: LSE

Country: GB : United Kingdom of Great Britain and Northern Ireland

Currency: US Dollar ($)

Forward PE: 0
Trailing PE: 0.322
Price-to-Book MRQ: 0
Price-to-Sales TTM: 4.9655
IPO Date:
Fiscal Year End: January
Full Time Employees: 10590
Back to stocks